Caliway Biopharmaceuticals Co Ltd(TW:6919)
NT$70.00-0.50 (-0.71%)
TW:6919
Caliway Biopharmaceuticals Co Ltd ownership
NT$70.00
At close:-0.50 (-0.71%)
Caliway Biopharmaceuticals Co Ltd (6919) Ownership - Who Owns Caliway Biopharmaceuticals Co Ltd?
Caliway Biopharmaceuticals Co Ltd (6919) Ownership Overview
- 4.15% ETFs
- 95.85% Public Companies and Individual Investors
The ownership structure of Caliway Biopharmaceuticals Co Ltd (TW:6919) stock is a mix of institutional, retail, and individual investors. Approximately 4.15% of the company’s stock is owned by Institutional Investors, and 95.85% is owned by Public Companies and Individual Investors.
The ownership structure of Caliway Biopharmaceuticals Co Ltd (TW:6919) stock is a mix of institutional, retail, and individual investors. Approximately 4.15% of the company’s stock is owned by Institutional Investors, and 95.85% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 35,646,766 | Institution | 2.29% | 76,391,020 |
| Ishares | 22,050,886 | Institution | 1.42% | 47,255,049 |
| Franklin | 2,866,564 | Institution | 0.18% | 6,143,047 |
| State Street | 1,589,740 | Institution | 0.10% | 3,406,813 |
| Schwab | 1,172,000 | Institution | 0.08% | 2,511,596 |
| Amundi | 481,071 | Institution | 0.03% | 1,030,935 |
| Spdr | 450,000 | Institution | 0.03% | 964,350 |
| Wisdomtree | 210,931 | Institution | 0.01% | 452,025 |
| Invesco | 170,000 | Institution | 0.01% | 364,310 |
| Northern Trust | 11,299 | Institution | <0.01% | 24,214 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VXUS ETF | 14,994,000 | Institution | 0.96% | 37,050,996 |
| Vanguard, VWO ETF | 14,380,000 | Institution | 0.92% | 35,533,768 |
| iShares, IEMG ETF | 12,043,000 | Institution | 0.77% | 23,771,168 |
| Vanguard, VEU ETF | 2,422,000 | Institution | 0.16% | 5,984,892 |
| Franklin, FLTW ETF | 2,216,000 | Institution | 0.14% | 4,335,534 |
| State Street, SPEM ETF | 1,498,000 | Institution | 0.10% | 3,031,734 |
| iShares, IXUS ETF | 1,414,000 | Institution | 0.09% | 2,791,035 |
| Schwab, SCHE ETF | 1,172,000 | Institution | 0.08% | 2,371,958 |
| Vanguard, VT ETF | 870,000 | Institution | 0.06% | 2,149,817 |
| Franklin, GB:FLXT ETF | 568,000 | Institution | 0.04% | 1,149,549 |
FAQ
What percentage of Caliway Biopharmaceuticals Co Ltd (TW:6919) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.15% of Caliway Biopharmaceuticals Co Ltd (TW:6919) stock is held by institutional investors.
What percentage of Caliway Biopharmaceuticals Co Ltd (TW:6919) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.85% of Caliway Biopharmaceuticals Co Ltd (TW:6919) stock is held by public companies and individual investors.
Who owns the most shares of Caliway Biopharmaceuticals Co Ltd (TW:6919)?
Vanguard owns the most shares of Caliway Biopharmaceuticals Co Ltd (TW:6919).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
